Daniel K Spiegelman insider trades
Open-market stock purchases and sales by Daniel K Spiegelman, Director at vTv Therapeutics Inc, from SEC Form 4 filings since Mar 29, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 26, 2026 | VTVT vTv Therapeutics Inc | Bought (not open market) | $210K |
| Jun 8, 2026 | MAZE Maze Therapeutics, Inc | Bought (not open market) | — |
| May 21, 2026 | SPRB Spruce Biosciences, Inc | Bought (not open market) | — |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | $47.7K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Sold (not open market) | $258K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | $9.2K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Sold (not open market) | $101K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Bought (not open market) | $41.7K |
| Dec 11, 2025 | SPRB Spruce Biosciences, Inc | Sold (not open market) | $67.8K |
Companies traded
- VTVT vTv Therapeutics Inc: other filings, last Jun 26, 2026
- MAZE Maze Therapeutics, Inc: other filings, last Jun 8, 2026
- SPRB Spruce Biosciences, Inc: other filings, last May 21, 2026
- KYTX Kyverna Therapeutics, Inc: other filings, last May 29, 2025
- MYGN Myriad Genetics Inc: 6 sales, last Jun 4, 2024
- BMRN Biomarin Pharmaceutical Inc: 37 sales, last Apr 30, 2019
- CASC Cascadian Therapeutics, Inc: other filings, last Mar 9, 2018
- RLYP Relypsa Inc: 1 sale, last Sep 1, 2016
- ONTY Oncothyreon Inc: 4 buys, 2 sales, last Sep 24, 2015
- ANTH Anthera Pharmaceuticals Inc: other filings, last Jun 13, 2014
- AFFY Affymax Inc: other filings, last Jun 13, 2012
- OMER Omeros Corp: other filings, last Jun 1, 2012
Get free alerts when Daniel K Spiegelman files a new trade →